Back to search

Article

Automated compound testing in zebrafish xenografts identifies combined MCL-1 and BCL-X <sub>L</sub> inhibition to be effective against Ewing sarcoma

2021-06-17

Abstract excerpt

Ewing sarcoma is a pediatric bone and soft tissue cancer for which new therapies to improve disease outcome and to reduce adverse effects of current standard treatments are urgently needed. To identify new and effective drugs, phenotypic drug screening has proven to be a powerful method and a cancer model ideally suited for this approach is the larval zebrafish xenograft system. Complementing mouse xenografts, zeb...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1e7939b6-6016-5db9-a6cb-6d2fdc55496f
DOI
10.1101/2021.06.17.448794
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Automated compound testing in zebrafish xenografts identifies combined MCL-1 and BCL-X <sub>L</sub> inhibition to be effective against Ewing sarcomaDOI 10.1101/2021.06.17.448794
Select a neighboring publication to make it the new centre.